Prednisolone Sodium Succinate

氢化泼尼松琥珀酸钠

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NamePrednisolone Sodium Succinate
Drug Alias Name氢泼琥钠
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsInflammationHypersensitivityAutoimmune Diseases +[5
Global Approved IndicationsInflammationHypersensitivityAutoimmune Diseases +[4
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1961/02/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShionogi Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationHypersensitivityAutoimmune Diseases +[5
Inactive IndicationsN/A

Other Information

ATC CodeA07EA01C05AA04D07AA03 +[10